Abramov I, Gordon J, Feldman O, Chavarga A Sex and vision II: color appearance of monochromatic lights. Biol Sex Differ. 2012 Sep 4;3(1):21. doi: 10.1186/2042-6410-3-21.
Capa N, Malkondu O, Kazazoglu E, Calikkocaoglu S Evaluating factors that affect the shade-matching ability of dentists, dental staff members and laypeople. J Am Dent Assoc. 2010 Jan;141(1):71-6.
Deeb SS The molecular basis of variation in human color vision. Clin Genet. 2005 May;67(5):369-77. Review.
Della Bona A, Barrett AA, Rosa V, Pinzetta C Visual and instrumental agreement in dental shade selection: three distinct observer populations and shade matching protocols. Dent Mater. 2009 Feb;25(2):276-81. doi: 10.1016/j.dental.2008.09.006. Epub 2008 Nov 18.
Hugo B, Witzel T, Klaiber B Comparison of in vivo visual and computer-aided tooth shade determination. Clin Oral Investig. 2005 Dec;9(4):244-50. Epub 2005 Oct 8.
Milagres V, Teixeira ML, Miranda ME, Osorio Silva CH, Ribeiro Pinto JR Effect of gender, experience, and value on color perception. Oper Dent. 2012 May-Jun;37(3):228-33. doi: 10.2341/10-057-C. Epub 2012 Feb 15. Erratum in: Oper Dent. 2012 Sep-Oct;37(5):558. Milagres, Viviane [added]; Teixeira, Marcelo Luchesi [added]; Osorio Silva, Carlos Henrique [added]; Ribeiro Pinto, Jose Renato [added].
Pecho OE, Ghinea R, Alessandretti R, Pérez MM, Della Bona A Visual and instrumental shade matching using CIELAB and CIEDE2000 color difference formulas. Dent Mater. 2016 Jan;32(1):82-92. doi: 10.1016/j.dental.2015.10.015. Epub 2015 Nov 28.
Influence of Gender on Visual Shade Matching in Dentistry
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
